Cargando…

Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial

Detalles Bibliográficos
Autores principales:	Metzner, Andreas, Suling, Anna, Brandes, Axel, Breithardt, Günter, Camm, A John, Crijns, Harry J G M, Eckardt, Lars, Elvan, Arif, Goette, Andreas, Haegeli, Laurent M, Heidbuchel, Hein, Kautzner, Josef, Kuck, Karl-Heinz, Mont, Luis, Ng, G Andre, Szumowski, Lukasz, Themistoclakis, Sakis, van Gelder, Isabelle C, Vardas, Panos, Wegscheider, Karl, Willems, Stephan, Kirchhof, Paulus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Corrigenda
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982426/ https://www.ncbi.nlm.nih.gov/pubmed/34897422 http://dx.doi.org/10.1093/europace/euab277

Ejemplares similares

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial
por: Metzner, Andreas, et al.
Publicado: (2021)

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
por: Willems, Stephan, et al.
Publicado: (2021)

Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial( )
por: Eckardt, Lars, et al.
Publicado: (2022)

Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
por: Willems, Stephan, et al.
Publicado: (2019)

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
por: Rillig, Andreas, et al.
Publicado: (2021)

Rationale and current perspective for early rhythm control therapy in atrial fibrillation
por: Van Gelder, Isabelle C., et al.
Publicado: (2011)

Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial
por: Gottschalk, Sophie, et al.
Publicado: (2023)

Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry
por: Haeusler, Karl Georg, et al.
Publicado: (2015)

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial
por: Kany, Shinwan, et al.
Publicado: (2023)

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
por: Reinecke, Holger, et al.
Publicado: (2018)

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
por: Schnabel, Renate B, et al.
Publicado: (2022)

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study
por: Reinecke, Holger, et al.
Publicado: (2022)

Generalizability of the EAST‐AFNET 4 Trial: Assessing Outcomes of Early Rhythm‐Control Therapy in Patients With Atrial Fibrillation
por: Dickow, Jannis, et al.
Publicado: (2022)

Atrial high-rate episodes and stroke prevention
por: Camm, A. John, et al.
Publicado: (2017)

AFNet Algorithm for Automatic Amniotic Fluid Segmentation from Fetal MRI
por: Costanzo, Alejo, et al.
Publicado: (2023)

The cryoballoon as a bailout in a severely perforated left atrial appendage: a case report
por: Metzner, Andreas, et al.
Publicado: (2018)

Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC – AFNET 9
por: Fabritz, Larissa, et al.
Publicado: (2022)

Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis
por: Merino, Jose L, et al.
Publicado: (2019)

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
por: Kirchhof, Paulus, et al.
Publicado: (2018)

Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation
por: Piccini, Jonathan P, et al.
Publicado: (2020)

Balloon Catheter Position and its Relationship with Esophageal Temperature during Pulmonary Vein Isolation using High-Intensity Focused Ultrasound
por: Neven, Kars, et al.
Publicado: (2012)

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality
por: Aliot, Etienne, et al.
Publicado: (2010)

Update Vorhofflimmern: Die ESC-Leitlinien 2020 sowie aktuelle Daten zur frühen antiarrhythmischen Therapie
por: Schleberger, Ruben, et al.
Publicado: (2021)

Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence
por: Bertaglia, Emanuele, et al.
Publicado: (2019)

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management
por: Nabauer, Michael, et al.
Publicado: (2009)

Catheter ablation for inappropriate sinus tachycardia: Clinical outcomes of sinus node ablation
por: Reissmann, Bruno, et al.
Publicado: (2019)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
por: Hohnloser, Stefan H, et al.
Publicado: (2020)

Catheter ablation for the treatment of persistent atrial fibrillation: Maintenance of sinus rhythm with left atrial appendage and coronary sinus isolation after multiple ablation procedures
por: Liang, Dong Po, et al.
Publicado: (2015)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Predictors of recurrence of atrial fibrillation within the first 3 months after ablation
por: Zink, Matthias Daniel, et al.
Publicado: (2020)

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
por: Hohnloser, Stefan H, et al.
Publicado: (2019)

High-quality and Fast Mapping of a Focal Atrial Tachycardia Arising from Koch’s Triangle
por: China, Paolo, et al.
Publicado: (2021)

Systematic Review on S-ICD Lead Extraction
por: Vio, Riccardo, et al.
Publicado: (2023)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation—Insights from the German Ablation Registry
por: Schleberger, Ruben, et al.
Publicado: (2021)

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
por: Aliot, Etienne, et al.
Publicado: (2011)

Radiofrequency ablation of premature ventricular contractions originating from the aortomitral continuity localized by use of a novel noninvasive epicardial and endocardial electrophysiology system()
por: Wissner, Erik, et al.
Publicado: (2016)

Psychological aspects of atrial fibrillation: A systematic narrative review: Impact on incidence, cognition, prognosis, and symptom perception
por: Ladwig, Karl-Heinz, et al.
Publicado: (2020)

European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers
por: Kotecha, Dipak, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hup27qts8ehij7ip47kk2k195v